Condition
Juvenile Idiopahtic Arthritis
Total Trials
4
Recruiting
1
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Completed2
Recruiting1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07543575Not ApplicableActive Not RecruitingPrimary
JIA Toolbox Feasibility Study
NCT07086989Recruiting
Cardiovascular Risk in Children With Chronic Conditions Study
NCT06609837CompletedPrimary
30-Second Sit-to-Stand Test for Assessing Functional Capacity in Juvenile Idiopathic Arthritis
NCT01421069Phase 3CompletedPrimary
Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis
Showing all 4 trials